Deutsche Bank’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$89.5K Sell
79,202
-20,342
-20% -$23K ﹤0.01% 3287
2025
Q1
$145K Buy
99,544
+92,981
+1,417% +$136K ﹤0.01% 3059
2024
Q4
$14K Sell
6,563
-62,616
-91% -$133K ﹤0.01% 3452
2024
Q3
$194K Buy
69,179
+30,994
+81% +$86.8K ﹤0.01% 2901
2024
Q2
$89K Sell
38,185
-6,699
-15% -$15.6K ﹤0.01% 3118
2024
Q1
$201K Buy
44,884
+2,222
+5% +$9.93K ﹤0.01% 2777
2023
Q4
$137K Sell
42,662
-628
-1% -$2.02K ﹤0.01% 3026
2023
Q3
$137K Sell
43,290
-193,776
-82% -$614K ﹤0.01% 2985
2023
Q2
$1.18M Sell
237,066
-210,884
-47% -$1.05M ﹤0.01% 1900
2023
Q1
$2.21M Buy
447,950
+1,200
+0.3% +$5.93K ﹤0.01% 1635
2022
Q4
$2.81M Buy
446,750
+6,939
+2% +$43.6K ﹤0.01% 1471
2022
Q3
$4.75M Sell
439,811
-47,820
-10% -$516K ﹤0.01% 1233
2022
Q2
$5.56M Buy
487,631
+98,865
+25% +$1.13M ﹤0.01% 1230
2022
Q1
$3.54M Buy
388,766
+44,240
+13% +$403K ﹤0.01% 1563
2021
Q4
$5.14M Buy
344,526
+132,937
+63% +$1.98M ﹤0.01% 1417
2021
Q3
$5.44M Sell
211,589
-22,194
-9% -$570K ﹤0.01% 1452
2021
Q2
$6.1M Buy
233,783
+33,832
+17% +$882K ﹤0.01% 1404
2021
Q1
$7.06M Sell
199,951
-60,967
-23% -$2.15M ﹤0.01% 1368
2020
Q4
$6.59M Buy
260,918
+206,099
+376% +$5.2M ﹤0.01% 1219
2020
Q3
$2.07M Sell
54,819
-9,795
-15% -$369K ﹤0.01% 1720
2020
Q2
$2.77M Buy
64,614
+49,351
+323% +$2.11M ﹤0.01% 1605
2020
Q1
$297K Sell
15,263
-3,512
-19% -$68.3K ﹤0.01% 2732
2019
Q4
$486K Buy
18,775
+7,291
+63% +$189K ﹤0.01% 2716
2019
Q3
$312K Sell
11,484
-10,280
-47% -$279K ﹤0.01% 2897
2019
Q2
$582K Sell
21,764
-18,950
-47% -$507K ﹤0.01% 3147
2019
Q1
$1.17M Buy
40,714
+3,414
+9% +$98.4K ﹤0.01% 2868
2018
Q4
$1M Buy
+37,300
New +$1M ﹤0.01% 2862